Cite
HARVARD Citation
Procopio, G. et al. (2014). Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting. Future oncology. pp. 1741-1750. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Procopio, G. et al. (2014). Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting. Future oncology. pp. 1741-1750. [Online].